
A groundbreaking randomized controlled trial reveals that daily multivitamins may slow biological aging in older adults, challenging previous…

Natera’s Signatera gains FDA approval, marking a pivotal shift in cancer treatment by utilizing ctDNA testing to guide…

The FDA’s approval of Langlara as an interchangeable biosimilar to Lantus promises to impact pricing in the long-acting…

A groundbreaking study tracking 47,513 women over 30 years reveals that high-quality carbohydrates in midlife significantly enhance the…

The FDA’s approval of Otarmeni marks a milestone in gene therapy, offering hope to children with OTOF hereditary…

A groundbreaking study published in JAMA Network Open reveals that older women who engage in regular strength training…

A groundbreaking study from UT Austin reveals daily exercise, not thrice-weekly workouts, significantly enhances deep sleep, offering actionable…

A groundbreaking cohort study reveals that early breakfast and prolonged overnight fasting are key to lower BMI, providing…

In 2026, a groundbreaking study explains why probiotics work for some but not all, offering a personalization map…

The recent ACC/AHA guideline elevates ApoB testing to a new standard in cardiovascular risk assessment, offering nuanced insights…